In:
Clinical Pharmacology & Therapeutics, Wiley, Vol. 101, No. 5 ( 2017-05), p. 589-592
Kurzfassung:
The cancer community understands the value of blood profiling measurements in assessing and monitoring cancer. We describe an effort among academic, government, biotechnology, diagnostic, and pharmaceutical companies called the Blood Profiling Atlas in Cancer (BloodPAC) Project. BloodPAC will aggregate, make freely available, and harmonize for further analyses, raw datasets, relevant associated clinical data (e.g., clinical diagnosis, treatment history, and outcomes), and sample preparation and handling protocols to accelerate the development of blood profiling assays.
Materialart:
Online-Ressource
ISSN:
0009-9236
,
1532-6535
Sprache:
Englisch
Verlag:
Wiley
Publikationsdatum:
2017
ZDB Id:
2040184-X
SSG:
15,3
Bookmarklink